Next Dynamics, Inc. (OTC: NEXD) (“Next Dynamics” or the “Company”), www.nextdynamicscorp.com, a leading Texas-based military technology company, is pleased to announce the grant of its patent in Israel (Patent No. 269699), entitled “IMPROVED BULLET, WEAPON PROVIDED WITH SUCH BULLETS, KIT FOR ASSEMBLING THE SAME, AND CORRESPONDING METHODS OF MANUFACTURING, OPERATING AND USE ASSOCIATED THERETO,” based upon the Company’s US Patent Nos. US11674779B2 and US11162768B2.
The official grant comes after a several years’ long review process including translation and other final procedural matters by the Company’s foreign patent associates.
The Israeli patent grant will enable Next Dynamics to more efficiently execute on its technology licensing strategy, bolstering the Company’s intellectual property protection in a country with first-rate technology development and an annual defense budget in excess of $30 billion, in a region that has also been rife with armed conflict since late 2023.
“Next Dynamics continues to further confirm the innovative nature of the Company’s ammunition technology and strengthen its intellectual property portfolio in key global regions,” said Chairman Andre Beauchesne. “We look forward to sharing more on the development of our next-generation ballistics technology, as well as on the acquisition of the strategic assets from BCL International Inc. and other M&A activity, in the very near future.”
About Next Dynamics, Inc.
Next Dynamics, Inc. (OTC: NEXD) is a publicly traded military technology company based in Texas, specializing in advanced defense solutions. The Company develops, manufactures, and distributes cutting-edge military equipment, ranging from weaponry and tactical vehicles to precision optics and protective gear. With a commitment to innovation and operational excellence, Next Dynamics serves government and private sector clients worldwide.
For more information, please visit www.nextdynamicscorp.com.
Media Contact:
Andre Beauchesne
Safe Harbor Forward-Looking Statements:
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, included in this press release are forward-looking statements. These include, but are not limited to, statements regarding the Company’s business strategy, anticipated growth, plans to develop, manufacture, and distribute advanced weaponry, military vehicles, firearms, and military clothing, as well as expectations regarding regulatory approvals, market opportunities, and operational performance. Forward-looking statements are based on management’s current expectations, estimates, and projections and involve significant risks and uncertainties. Actual results may differ materially from those described in such statements due to various factors, including, but not limited to, uncertainties related to product development, supply chain logistics, customer demand, geopolitical factors, compliance with government regulations, and the Company’s ability to secure contracts and financing to support its operations. The Company is not required to file periodic reports under Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended. However, the Company provides current and periodic information in accordance with Rule 15c2-11, and such disclosures are made publicly available through OTC Markets Group. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. Words such as “estimate,” “project,” “predict,” “will,” “would,” “should,” “could,” “may,” “might,” “anticipate,” “plan,” “intend,” “believe,” “expect,” “aim,” “goal,” “target,” “objective,” “likely” or similar expressions that convey the prospective nature of events or outcomes generally indicate forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.